ReBioStent – Reinforced Bioresorbable Biomaterials for Therapeutic Drug Eluting Stents (CP-TP – NMP Programme)
The ReBioStent project (Reinforced Bioresorbable Biomaterials for Therapeutic Drug Eluting Stents) is a Project addressing the European Union’s Seventh Framework Programme (FP7) work programme Theme on Biomaterials for Advanced Therapies and Medical Devices in the neurological/neuromuscular or cardiovascular fields. The aim of this project is to develop a resorbable cardiovascular stent that will replace the current metallic stents, translating in the main objective of developing multifunctional biomaterials for Reinforced Bioresorbable Therapeutic Drug Eluting Stents. These newly developed biomaterials will be drug-loaded, bioresorbable with improved mechanical properties, reducing the risk of in-stent restenosis, thrombosis, and surface functionalisation to promote rapid endothelialisation.